CytomX Therapeutics, Inc. (CTMX) SEC filings
CTMX SEC filings moved a median of -0.95% by the close. CTMX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CTMX overview →
56 measured CTMX SEC filing events.
Where these CTMX SEC filings landedvs 55 measured CTMX SEC filing reactions
| Middle 50% of CTMX SEC filing reactions | -4.98% to +3.92% |
|---|---|
| Median reaction (to close) | -0.95% |
| Measured reactions | 55 |
Point-in-time · zero look-ahead
Half of the 55 CTMX SEC filing events with a measured close landed between -4.98% and +3.92%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q CytomX Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.60% | +4.22% | |
| Form 8-K CytomX Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +0.60% | +4.22% | |
| Form S-8 CytomX Therapeutics, | SEC filing · Form S-8 | +0.60% | +4.22% | |
| Form 8-K CytomX Therapeutics, For: Jul 24 | SEC filing · Form 8-K | +1.23% | +0.00% | |
| Form 8-K CytomX Therapeutics, For: Jun 17 | SEC filing · Form 8-K | +0.66% | +3.62% | |
| Form 8-K CytomX Therapeutics, For: May 29 | SEC filing · Form 8-K | +0.15% | -1.55% | |
| Form 10-Q CytomX Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.98% | -1.49% | |
| Form 8-K CytomX Therapeutics, For: May 07 | SEC filing · Form 8-K | +1.98% | -1.49% | |
| Form DEF 14A CytomX Therapeutics, For: Jun 17 | SEC filing · Form DEF | +1.30% | -0.95% | |
| Form DEFA14A CytomX Therapeutics, | SEC filing · Form DEFA14A | +1.30% | -0.95% | |
| Form PRE 14A CytomX Therapeutics, For: Jun 17 | SEC filing · Form PRE | +1.43% | -2.66% | |
| Form 8-K CytomX Therapeutics, For: Mar 17 | SEC filing · Form 8-K | -0.88% | -3.26% | |
| Form 10-K CytomX Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.20% | -2.74% | |
| Form 8-K CytomX Therapeutics, For: Mar 16 | SEC filing · Form 8-K | -6.20% | -2.74% | |
| Form S-3ASR CytomX Therapeutics, | SEC filing · Form S-3ASR | -2.60% | -21.13% | |
| Form 10-Q CytomX Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -4.74% | -4.74% | |
| Form 8-K CytomX Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -4.74% | -4.74% | |
| Form EFFECT CytomX Therapeutics, | SEC filing · Form EFFECT | -0.71% | — | |
| Form 8-K CytomX Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +2.10% | -6.58% | |
| Form 10-Q CytomX Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.93% | +14.63% | |
| Form 8-K CytomX Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +2.93% | +14.63% | |
| Form S-3 CytomX Therapeutics, | SEC filing · Form S-3 | +2.93% | +14.63% | |
| Form S-8 CytomX Therapeutics, | SEC filing · Form S-8 | +2.93% | +14.63% | |
| Form 8-K CytomX Therapeutics, For: Jun 11 | SEC filing · Form 8-K | -4.59% | -13.07% | |
| Form 8-K CytomX Therapeutics, For: May 27 | SEC filing · Form 8-K | +2.92% | +5.00% | |
| Form 8-K CytomX Therapeutics, For: May 12 | SEC filing · Form 8-K | -8.86% | +0.42% | |
| Form 10-Q CytomX Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +5.26% | +12.11% | |
| Form 8-K CytomX Therapeutics, For: May 12 | SEC filing · Form 8-K | +5.26% | +12.11% | |
| Form DEF 14A CytomX Therapeutics, For: Jun 11 | SEC filing · Form DEF | -5.56% | -9.50% | |
| Form DEFA14A CytomX Therapeutics, | SEC filing · Form DEFA14A | -5.56% | -9.50% | |
| Form 10-K CytomX Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.38% | -6.35% | |
| Form 8-K CytomX Therapeutics, For: Mar 06 | SEC filing · Form 8-K | -2.38% | -6.35% | |
| Form S-8 CytomX Therapeutics, | SEC filing · Form S-8 | -2.38% | -6.35% | |
| Form 8-K CytomX Therapeutics, For: Feb 24 | SEC filing · Form 8-K | +4.48% | +0.78% | |
| Form 8-K CytomX Therapeutics, For: Jan 30 | SEC filing · Form 8-K | +1.18% | +1.64% | |
| Form 8-K CytomX Therapeutics, For: Jan 06 | SEC filing · Form 8-K | -7.39% | -11.30% | |
| Form 10-Q CytomX Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -5.22% | |
| Form 8-K CytomX Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +0.00% | -5.22% | |
| Form EFFECT CytomX Therapeutics, | SEC filing · Form EFFECT | +1.23% | +1.64% | |
| Form S-3 CytomX Therapeutics, | SEC filing · Form S-3 | +1.27% | +0.85% | |
| Form 10-Q CytomX Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.68% | +0.84% | |
| Form 8-K CytomX Therapeutics, For: Aug 08 | SEC filing · Form 8-K | +1.68% | +0.84% | |
| Form 8-K CytomX Therapeutics, For: Jun 12 | SEC filing · Form 8-K | -3.17% | -9.15% | |
| Form 8-K CytomX Therapeutics, For: May 15 | SEC filing · Form 8-K | -1.57% | +0.52% | |
| Form 10-Q CytomX Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -8.43% | -25.27% | |
| Form 8-K CytomX Therapeutics, For: May 08 | SEC filing · Form 8-K | -8.43% | -25.27% | |
| Form DEFA14A CytomX Therapeutics, | SEC filing · Form DEFA14A | -6.46% | +57.85% | |
| Form DEF 14A CytomX Therapeutics, For: May 15 | SEC filing · Form DEF | -0.24% | -0.48% | |
| Form DEFA14A CytomX Therapeutics, | SEC filing · Form DEFA14A | -0.24% | -0.48% | |
| Form PRE 14A CytomX Therapeutics, For: May 15 | SEC filing · Form PRE | -2.31% | -2.31% | |
| Form 8-K CytomX Therapeutics, For: Mar 20 | SEC filing · Form 8-K | +0.17% | +0.47% | |
| Form 10-K CytomX Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.00% | +7.50% | |
| Form 8-K CytomX Therapeutics, For: Mar 11 | SEC filing · Form 8-K | +2.00% | +7.50% | |
| Form S-8 CytomX Therapeutics, | SEC filing · Form S-8 | +2.00% | +7.50% | |
| Form 10-Q CytomX Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -3.10% | |
| Form 8-K CytomX Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +0.00% | -3.10% |
Keep exploring
More CTMX: earnings → · analyst actions → · CTMX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CONMED Corporation (CNMD) | 268 | -0.11% | 47% |
| Codexis, Inc. (CDXS) | 267 | 0.00% | 51% |
| Galapagos NV - American Depositary Shares (GLPG) | 267 | -0.05% | 44% |
| Eyenovia, Inc. (EYEN) | 266 | -0.95% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.